Arne Michael Taxt

  • MD, Phd

Publications 2022

Avershina E, Frye SA, Ali J, Taxt AM, Ahmad R (2022)
Ultrafast and Cost-Effective Pathogen Identification and Resistance Gene Detection in a Clinical Setting Using Nanopore Flongle Sequencing
Front Microbiol, 13, 822402
DOI 10.3389/fmicb.2022.822402, PubMed 35369431

Publications 2021

Avershina E, Sharma P, Taxt AM, Singh H, Frye SA, Paul K, Kapil A, Naseer U, Kaur P, Ahmad R (2021)
AMR-Diag: Neural network based genotype-to-phenotype prediction of resistance towards β-lactams in Escherichia coli and Klebsiella pneumoniae
Comput Struct Biotechnol J, 19, 1896-1906
DOI 10.1016/j.csbj.2021.03.027, PubMed 33897984

Borud EK, Nakstad ER, Håberg SE, Lind A, Fadum EA, Taxt AM, Steens A, Gjein GE, Sunde MW, Iversen P, Svanevik M, Ahmad BM, Waldow T, Norheim AJ (2021)
Severe acute respiratory syndrome coronavirus 2 prevalence in 1170 asymptomatic Norwegian conscripts
Health Sci Rep, 4 (1), e233
DOI 10.1002/hsr2.233, PubMed 33490637

Brandal LT, MacDonald E, Veneti L, Ravlo T, Lange H, Naseer U, Feruglio S, Bragstad K, Hungnes O, Ødeskaug LE, Hagen F, Hanch-Hansen KE, Lind A, Watle SV, Taxt AM, Johansen M, Vold L, Aavitsland P, Nygård K, Madslien EH (2021)
Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
Euro Surveill, 26 (50)
DOI 10.2807/1560-7917.ES.2021.26.50.2101147, PubMed 34915975

Landaas ET, Taxt AM, Lind A, Müller F (2021)
[The COVID-19 pandemic – experiences from a microbiology laboratory]
Tidsskr Nor Laegeforen, 141 (18)
DOI 10.4045/tidsskr.21.0643, PubMed 34911278

Norheim AJ, Borud EK, Lind A, Fadum EA, Taxt A, Steens A, Bragstad K, Rein E, Nakstad E (2021)
Pre-screening and preventive quarantine likely explains the low SARS-CoV-2 prevalence among Norwegian conscripts
Scand J Prim Health Care, 39 (1), 31-34
DOI 10.1080/02813432.2021.1880101, PubMed 33544016

Ramstad SN, Brandal LT, Taxt AM, Wasteson Y, Bjørnholt JV, Naseer U (2021)
Prevalence of genotypic antimicrobial resistance in clinical Shiga toxin-producing Escherichia coli in Norway, 2018 to 2020
J Med Microbiol, 70 (12)
DOI 10.1099/jmm.0.001454, PubMed 34870582

Ramstad SN, Wasteson Y, Lindstedt BA, Taxt AM, Bjørnholt JV, Brandal LT, Bohlin J (2021)
Characterization of Shiga Toxin 2a Encoding Bacteriophages Isolated From High-Virulent O145:H25 Shiga Toxin-Producing Escherichia coli
Front Microbiol, 12, 728116
DOI 10.3389/fmicb.2021.728116, PubMed 34566932

Seppälä E, Veneti L, Starrfelt J, Danielsen AS, Bragstad K, Hungnes O, Taxt AM, Watle SV, Meijerink H (2021)
Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021
Euro Surveill, 26 (35)
DOI 10.2807/1560-7917.ES.2021.26.35.2100793, PubMed 34477054

Publications 2020

Norheim AJ, Lind A, Taxt AM, Nakstad ER, Borud EK, Waldow T (2020)
Asymptomatic COVID-19 with ambiguous test results
Tidsskr Nor Laegeforen, 140 (18)
DOI 10.4045/tidsskr.20.0658, PubMed 33322866

Norheim AJ, Lind A, Taxt AM, Nakstad ER, Borud EK, Waldow T (2020)
Asymptomatic COVID-19 with ambiguous test results
Tidsskr. Nor. Laegeforen., 140 (18), 1908-1910

Ramstad SN, Taxt AM, Naseer U, Wasteson Y, Bjørnholt JV, Brandal LT (2020)
Effects of antimicrobials on Shiga toxin production in high-virulent Shiga toxin-producing Escherichia coli
Microb Pathog, 152, 104636
DOI 10.1016/j.micpath.2020.104636, PubMed 33242644

Taxt AM, Avershina E, Frye SA, Naseer U, Ahmad R (2020)
Rapid identification of pathogens, antibiotic resistance genes and plasmids in blood cultures by nanopore sequencing
Sci Rep, 10 (1), 7622
DOI 10.1038/s41598-020-64616-x, PubMed 32376847

Taxt AM, Grødeland G, Lind A, Müller F (2020)
Status of COVID-19 vaccine development
Tidsskr Nor Laegeforen, 140 (13)
DOI 10.4045/tidsskr.20.0676, PubMed 32998488

Publications 2018

Govasli ML, Diaz Y, Zegeye ED, Darbakk C, Taxt AM, Puntervoll P (2018)
Purification and Characterization of Native and Vaccine Candidate Mutant Enterotoxigenic Escherichia coli Heat-Stable Toxins
Toxins (Basel), 10 (7)
DOI 10.3390/toxins10070274, PubMed 29970812

Publications 2016

Taxt AM (2016)
[Not Available]
Tidsskr Nor Laegeforen, 136 (4), 339
DOI 10.4045/tidsskr.15.1333, PubMed 26905853

Taxt AM, Diaz Y, Aasland R, Clements JD, Nataro JP, Sommerfelt H, Puntervoll P (2016)
Towards Rational Design of a Toxoid Vaccine against the Heat-Stable Toxin of Escherichia coli
Infect Immun, 84 (4), 1239-1249
DOI 10.1128/IAI.01225-15, PubMed 26883587

Publications 2014

Taxt AM, Diaz Y, Bacle A, Grauffel C, Reuter N, Aasland R, Sommerfelt H, Puntervoll P (2014)
Characterization of immunological cross-reactivity between enterotoxigenic Escherichia coli heat-stable toxin and human guanylin and uroguanylin
Infect Immun, 82 (7), 2913-22
DOI 10.1128/IAI.01749-14, PubMed 24778111

Publications 2010

Taxt A, Aasland R, Sommerfelt H, Nataro J, Puntervoll P (2010)
Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target
Infect Immun, 78 (5), 1824-31
DOI 10.1128/IAI.01397-09, PubMed 20231404

Publications 2008

Stabell N, Nordal E, Stensvold E, Gammelsrud KW, Lund B, Taxt A, Buhring F, Greve-Isdahl M, Fornebo HP, Simonsen GS, Klingenberg C (2008)
Febrile neutropenia in children with cancer: a retrospective Norwegian multicentre study of clinical and microbiological outcome
Scand J Infect Dis, 40 (4), 301-7
DOI 10.1080/00365540701670436, PubMed 17918015

Publications 2003

Larsen TH, Taxt AM, Aslaksen A, Segadal L, Norgård G, Røksund OD, Greve G (2003)
Magnetic resonance imaging of patients with increased blood pressure and altered blood pressure response to exercise after coarctation repair
Scand Cardiovasc J, 37 (2), 98-103
DOI 10.1080/14017430310001203, PubMed 12775309

Page visits: 1825